Portable Rapid Imaging for Medical Emergencies (PRIME)

May 28, 2026 updated by: Yale University
This study will compare the time it takes to scan a patient in the emergency department with a portable MRI when compared to a conventional MRI. Participants will be randomized to receive a portable MRI plus standard of care (SOC) vs SOC. Investigators will look at time to beginning of scan for both.

Study Overview

Detailed Description

The primary objective of this study is to determine whether portable brain MRI reduces the time from scan order to scan start in the emergency department as compared to conventional brain MRI. The secondary objectives of this study are 1) to measure the percentage of scans that are completed after order and the time from order to completion, 2) to compare findings on portable MRI to conventional brain imaging findings, 3) to compare the total length of stay between the portable MRI and conventional MRI groups, and 4) to understand the impact of portable MRI scans on decision making and provider satisfaction based on qualitative surveys administered to a physician endpoint panel. This is a prospective, observational, randomized study. Participants will be recruited from the pool of patients ordered for a brain MRI, with or without contrast and excluding hyperacute MRI, in the emergency department. Participants will be randomized to one of two treatment groups, scan or standard-of-care (SOC). Participants in the scan arm will receive a portable MRI scan as soon as the scanner is available after randomization.

Participants in the SOC arm will not receive a portable MRI scan as part of their initial evaluation. Regardless of randomization arm, all participants will receive their scheduled conventional MRI as usual. Information on each participant's clinical course, conventional imaging, and length of stay will be collected, regardless of treatment group. On a rolling basis, surveys containing deidentified clinical information and portable MRI scans will be administered to a physician panel to assess the impact of portable MRI scans on decision making and provider satisfaction.

Study Type

Interventional

Enrollment (Actual)

100

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Connecticut
      • New Haven, Connecticut, United States, 06520
        • Yale New Haven Health Emergency Department

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Male or female ≥ 18 years of age at presentation to Yale New Haven Hospital Adult ED
  • Order to receive conventional brain MRI imaging originating in the YNHH Adult ED

Exclusion Criteria:

  • Lack of assent from treating physician for inclusion in this protocol.
  • Contraindications to 1.5T MRI evaluation, including:

    1. Cardiac Pacemaker or defibrillator
    2. Aneurysm clip
    3. Implants or devices attached to the body in the chest or above, such as:

      1. Nerve stimulator
      2. Deep brain stimulator
      3. Programmable shunt
      4. Stent
      5. Pain pump
      6. Artificial extremity
    4. Implants in the ears (hearing aid or cochlear implant
    5. Any shrapnel, pellets, bullets, metallic fragments, or other metallic foreign body above the chest
    6. Metallic joints, rods, screws, or other orthopedic implants in or above the chest
    7. Braces, dentures, removable teeth, or dental expanders that cannot be removed.
    8. Body piercings in or above the chest that cannot be removed.
    9. MRI-incompatible Tracheostomy tube or Swan Ganz catheter in place
    10. Status Epilepticus or anyone previously seizing deemed by the physician not to be suitable for pMRI

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Diagnostic
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Portable Brain MRI scan
Participants in the scan arm will receive a portable MRI scan as soon as the scanner is available after randomization as part of their initial evaluation. Regardless of randomization arm, all participants will receive their scheduled conventional MRI as usual.
portable brain MRI scanner
No Intervention: Standard of Care
Participants in the SOC arm will not receive a portable MRI scan as part of their initial evaluation. Regardless of randomization arm, all participants will receive their scheduled conventional MRI as usual.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Time to start of scan
Time Frame: immediately post MRI (Day 1)
The primary outcome is time from MRI order to assigned arm scan initiation, analyzed as cumulative initiation at the prespecified time points of 3,6,9, and 12 hours.
immediately post MRI (Day 1)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Portable MRI Findings
Time Frame: immediately post MRI (Day 1)
The frequency of acute findings (e.g., ischemic stroke, intracranial hemorrhage) using the portable MRI will be compared between groups.
immediately post MRI (Day 1)
Length of Stay
Time Frame: immediately post MRI (Day 1)
Total Emergency Department length of stay
immediately post MRI (Day 1)
Non-Completed Scans
Time Frame: immediately post missed MRI (Day 1)
To document the reasons for non-completion of MRI scans
immediately post missed MRI (Day 1)
Time to scan during hospital encounter
Time Frame: immediately post MRI (Day 1)
Time in hours from MRI order to scan initiation among participants whose assigned examination was initiated during the same hospital encounter.
immediately post MRI (Day 1)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Collaborators

Investigators

  • Principal Investigator: Adam de Havenon, MD, Yale University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 21, 2025

Primary Completion (Actual)

December 3, 2025

Study Completion (Actual)

December 3, 2025

Study Registration Dates

First Submitted

March 19, 2025

First Submitted That Met QC Criteria

April 8, 2025

First Posted (Actual)

April 16, 2025

Study Record Updates

Last Update Posted (Actual)

June 2, 2026

Last Update Submitted That Met QC Criteria

May 28, 2026

Last Verified

May 1, 2026

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • 2000039013

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

Yes

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Patient Satisfaction

Clinical Trials on Swoop Plus Mk2.0

Subscribe